NCT06499194Completed
Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension
Source: ClinicalTrials.gov · Last updated 12 Jul 2024
Brief summary (registry, in English)
DASH diet can reduce hypertension and decrease health expenses
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 364 (actual)
- First submitted
- 6 Jul 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 29 Oct 2023
- Lead sponsor
- Beni-Suef University
- Diseases
- High blood pressure
- NCT number
- NCT06499194
What you commit to
- Study type: Interventional
- Participants enrolled: 364
- From 1 Jan 2023 to the primary completion date, 29 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Patients with cancer and either hepatic failure or renal impairment.
- Patients diagnosed with diabetes, metabolic illness, or terminal organ failure.
- A patient with severe or malignant hypertension.
- Individuals who decline to partake in our research.
Who the study is looking for
- patients diagnosed with primary hypertension (all stages) in the family medicine units of Esna Health Administration, located in Luxor Governorate.
- Individuals between the ages of 30 and 60, of both male and female genders.
Age in the registry: 30 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine Coordinator of this site? Confirm its status | Banī Suwayf | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.